V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014940 | 160007377 | 1.77 | 70.3 | Curative (C) | 2018-01-04 | 2018-01-04 | Doxorubicin + Ifosfamide | N | N | DOXORUBICIN | 101064435 |
| 160014943 | 160007378 | 1.64 | 61 | null | 2016-05-17 | 2016-05-17 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | 01 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100188528 |
| 160014945 | 160007379 | 1.76 | 72.4 | null | 2019-02-02 | 2019-02-06 | NB HRNBL-1 MOD N7 CAV | 02 | N | GEMCITABINE | 101660218 |
| 160014948 | 160007380 | 1.82 | 59.2 | Palliative (P) | 2018-05-02 | 2018-05-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100032259 |
| 160014949 | 160007381 | 1.68 | 55 | null | 2016-09-01 | 2016-09-02 | Cisplatin + Doxorubicin | 02 | null | DOXORUBICIN | 101784548 |
| 160014950 | 160007382 | 1.95 | 74.1 | Palliative (P) | 2017-04-19 | 2017-05-03 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100183789 |
| 160014951 | 160007383 | 1.88 | 72.6 | Palliative (P) | 2019-02-05 | 2019-02-12 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101002376 |
| 160014952 | 160007384 | 1.46 | 71 | Disease modification (D) | 2017-08-10 | 2017-08-11 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 2 | N | PACLITAXEL | 101103873 |
| 160014953 | 160007385 | 1.82 | 69.2 | 03 | 2021-10-12 | 2021-10-26 | VIDE | N | N | DOXORUBICIN + IFOSFAMIDE | 101448657 |
| 160014954 | 160007386 | 1.55 | null | Palliative (P) | 2012-05-01 | 2012-05-21 | null | 02 | N | CARBOPLATIN | 100520771 |
| 160014958 | 160007387 | 1.78 | 83.1 | Palliative (P) | 2018-08-07 | 2018-08-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100555569 |
| 160014959 | 160007388 | 1.67 | 88.2 | Curative (C) | 2019-05-21 | 2019-06-04 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | LIPOSOMAL DOXORUBICIN | 101613257 |
| 160014960 | 160007389 | 1.76 | 64 | Palliative (P) | 2017-04-04 | 2017-04-04 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101013713 |
| 160014961 | 160007390 | 1.79 | 63.5 | Neo-adjuvant (N) | 2017-11-17 | 2017-12-17 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101374564 |
| 160014962 | 160007391 | null | null | null | 2016-06-01 | 2016-06-04 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 02 | null | CONFIRM TRIAL | 100034462 |
| 160014963 | 160007392 | null | 60.1 | Palliative (P) | 2019-02-04 | 2019-02-15 | Docetaxel+Gemcitabine (no prior RT) | N | null | ETOP 13-18 BEAT-MESO TRIAL | 100867830 |
| 160014966 | 160007393 | null | 63.5 | null | 2021-04-22 | 2021-06-15 | Cisplatin + Pemetrexed | 02 | 2 | CISPLATIN + PEMETREXED | 101822031 |
| 160014967 | 160007394 | null | null | Palliative (P) | 2017-07-30 | 2017-08-21 | DOXORUBICIN | 02 | null | LIPOSOMAL DAUNORUBICIN | 101446011 |
| 160014968 | 160007395 | 1.73 | 80.7 | Palliative (P) | 2018-01-14 | 2018-01-15 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101097557 |
| 160014969 | 160007396 | 1.87 | 83.85 | Curative (C) | null | 2018-12-31 | Trial Unspecified | 02 | null | IFOSFAMIDE | 101330815 |
| 160014970 | 160007397 | 1.81 | 93.2 | Palliative (P) | 2019-04-29 | 2019-05-18 | VIDE | 02 | N | CISPLATIN + VINORELBINE | 101646344 |
| 160014971 | 160007398 | 1.71 | 59.6 | Palliative (P) | 2019-12-01 | 2019-12-08 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101590601 |
| 160014972 | 160007399 | 1.6 | 64.8 | Neo-adjuvant (N) | 2020-01-15 | 2020-01-15 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100057296 |
| 160014974 | 160007400 | 1.67 | 67.2 | null | 2016-02-06 | 2016-02-14 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 101260523 |
| 160014978 | 160007401 | 1.69 | 71.4 | Palliative (P) | null | 2019-08-24 | LANREOTIDE | 02 | N | PEMETREXED | 100625851 |
| 160014980 | 160007402 | 1.75 | 82 | Curative (C) | 2018-03-03 | 2018-03-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100778701 |
| 160014983 | 160007403 | 1.86 | 33 | Palliative (P) | 2020-02-09 | 2020-02-09 | CYCLOPHOSPHAMIDE | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101041597 |
| 160014984 | 160007404 | 1.59 | 78.8 | Palliative (P) | 2016-06-20 | 2016-06-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100528507 |
| 160014985 | 160007405 | 1.72 | 90 | Palliative (P) | 2017-07-08 | 2017-07-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | DOXORUBICIN + OLARATUMAB | 100108021 |
| 160014986 | 160007406 | 1.77 | 103.2 | Palliative (P) | 2019-08-13 | 2019-08-18 | Trial Unspecified | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100261685 |
| 160014987 | 160007407 | 1.71 | 79 | Palliative (P) | 2019-06-12 | 2019-06-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100465615 |
| 160014988 | 160007408 | null | 87 | Palliative (P) | 2017-03-18 | 2017-03-25 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 02 | N | CISPLATIN + DOXORUBICIN | 101140238 |
| 160014992 | 160007409 | 1.55 | 70 | Disease modification (D) | 2015-12-01 | 2015-12-17 | EW EuroEwing 2012 Arm B VDC | 02 | N | TRIAL UNSPECIFIED | 101831243 |
| 160014994 | 160007410 | 1.63 | 99.5 | Palliative (P) | 2016-01-07 | 2016-02-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100444770 |
| 160014995 | 160007411 | 1.61 | 73.6 | Disease modification (D) | 2018-12-07 | 2018-12-23 | Doxorubicin + Olaratumab | 02 | N | CARBOPLATIN | 100896234 |
| 160014996 | 160007412 | 1.77 | 72 | Curative (C) | 2017-10-18 | 2017-10-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100985882 |
| 160014998 | 160007413 | 1.81 | 74.9 | Palliative (P) | 2015-11-08 | 2015-11-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100967917 |
| 160014999 | 160007414 | 1.57 | 76 | Curative (C) | 2017-12-23 | 2017-12-30 | ETOP 13-18 BEAT-meso Trial | null | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100750262 |
| 160015003 | 160007415 | 1.76 | 88 | 03 | 2016-11-13 | 2016-12-01 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100430426 |
| 160015004 | 160007416 | 0 | 0 | null | 2015-11-04 | 2015-11-06 | VAC | N | Y | DOXORUBICIN + IFOSFAMIDE | 101529324 |
| 160015005 | 160007417 | 1.82 | 85 | Neo-adjuvant (N) | null | 2017-08-27 | EW EuroEwing 2012 Arm B VDC | 02 | N | CAPECITABINE | 100317125 |
| 160015006 | 160007418 | null | 97.85 | Curative (C) | 2018-06-24 | 2018-06-24 | ETOP 13-18 BEAT-meso Trial | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100328403 |
| 160015009 | 160007419 | 1.86 | 99.9 | Curative (C) | 2019-02-12 | 2019-02-26 | IVADo | 02 | N | BENDAMUSTINE + RITUXIMAB | 100565523 |
| 160015011 | 160007420 | 1.77 | 70.5 | Curative (C) | 2017-04-14 | 2017-04-16 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100077988 |
| 160015012 | 160007421 | 1.78 | 77.5 | Palliative (P) | 2016-08-02 | 2016-08-05 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100715994 |
| 160015015 | 160007423 | 1.86 | 93.4 | Palliative (P) | 2016-05-15 | 2016-06-09 | Doxorubicin + Olaratumab | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100668681 |
| 160015018 | 160007424 | 1.69 | 65.25 | Palliative (P) | 2017-04-14 | 2017-04-21 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101832578 |
| 160015019 | 160007425 | 1.82 | 69 | Neo-adjuvant (N) | 2018-11-03 | 2018-11-04 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101607223 |
| 160015022 | 160007426 | 1.66 | 75 | Palliative (P) | 2016-03-26 | 2016-03-30 | Doxorubicin + Olaratumab | N | N | DOXORUBICIN + OLARATUMAB | 100531281 |
| 160015024 | 160007427 | 1.6 | 88.7 | Palliative (P) | 2020-01-02 | 2020-01-26 | Carboplatin + Paclitaxel (weekly) | Y | N | CARBOPLATIN + PACLITAXEL | 100665641 |